Real World Evidence of Effectiveness of COVID-19 Vaccines and Anti SARS-CoV-2 Monoclonal Antibodies Against Post-Acute Sequelae of SARS-CoV-2 Infection
Jonika Tannous, View ORCID ProfileAlan P. Pan, Thomas Potter, Abdulaziz Bako, Katharine Dlouhy, Ashley Drews, H. Dirk Sostman, View ORCID ProfileFarhaan S. Vahidy
doi: https://doi.org/10.1101/2022.06.30.22277105
Jonika Tannous
1Center for Health Data Science and Analytics, Houston Methodist, Houston TX
PhDAlan P. Pan
1Center for Health Data Science and Analytics, Houston Methodist, Houston TX
MSThomas Potter
1Center for Health Data Science and Analytics, Houston Methodist, Houston TX
PhDAbdulaziz Bako
1Center for Health Data Science and Analytics, Houston Methodist, Houston TX
MBBS MPH PhDKatharine Dlouhy
1Center for Health Data Science and Analytics, Houston Methodist, Houston TX
BSAshley Drews
2Houston Methodist Academic Institute, Houston Methodist, Houston TX
3Department of Population Health Sciences, Weill Cornell Medicine, New York NY
MDH. Dirk Sostman
2Houston Methodist Academic Institute, Houston Methodist, Houston TX
3Department of Population Health Sciences, Weill Cornell Medicine, New York NY
MDFarhaan S. Vahidy
1Center for Health Data Science and Analytics, Houston Methodist, Houston TX
2Houston Methodist Academic Institute, Houston Methodist, Houston TX
3Department of Population Health Sciences, Weill Cornell Medicine, New York NY
PhD MBBS MPHData Availability
All data produced in the present study are available upon reasonable request to the authors after necessary approvals and processes have been completed
Posted July 02, 2022.
Real World Evidence of Effectiveness of COVID-19 Vaccines and Anti SARS-CoV-2 Monoclonal Antibodies Against Post-Acute Sequelae of SARS-CoV-2 Infection
Jonika Tannous, Alan P. Pan, Thomas Potter, Abdulaziz Bako, Katharine Dlouhy, Ashley Drews, H. Dirk Sostman, Farhaan S. Vahidy
medRxiv 2022.06.30.22277105; doi: https://doi.org/10.1101/2022.06.30.22277105
Real World Evidence of Effectiveness of COVID-19 Vaccines and Anti SARS-CoV-2 Monoclonal Antibodies Against Post-Acute Sequelae of SARS-CoV-2 Infection
Jonika Tannous, Alan P. Pan, Thomas Potter, Abdulaziz Bako, Katharine Dlouhy, Ashley Drews, H. Dirk Sostman, Farhaan S. Vahidy
medRxiv 2022.06.30.22277105; doi: https://doi.org/10.1101/2022.06.30.22277105
Subject Area
Subject Areas
- Addiction Medicine (351)
- Allergy and Immunology (674)
- Anesthesia (181)
- Cardiovascular Medicine (2667)
- Dermatology (225)
- Emergency Medicine (404)
- Epidemiology (12284)
- Forensic Medicine (10)
- Gastroenterology (766)
- Genetic and Genomic Medicine (4134)
- Geriatric Medicine (387)
- Health Economics (682)
- Health Informatics (2681)
- Health Policy (1008)
- Hematology (365)
- HIV/AIDS (856)
- Medical Education (400)
- Medical Ethics (109)
- Nephrology (443)
- Neurology (3922)
- Nursing (212)
- Nutrition (583)
- Oncology (2057)
- Ophthalmology (592)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1122)
- Primary Care Research (458)
- Public and Global Health (6557)
- Radiology and Imaging (1411)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (454)
- Toxicology (54)
- Transplantation (188)
- Urology (168)